5 Star Equine Joins NCHA Corporate Partnership Family

Quality Saddle Pads Featured in NCHA Prize Packages

For top cutting horses, the stress of a rider and saddle can be hard on the shoulders, withers and back, so a high-quality saddle pad is a must in the sport. Bringing that quality to the cutting horse world is 5 Star Equine Products and Supplies of Hatfield, Arkansas, the newest corporate partner for the National Cutting Horse Association (NCHA).

“NCHA continually works to introduce companies to the cutting horse audience who will provide superior products at the best price,” said NCHA Executive Director Jim Bret Campbell. “5 Star has repeatedly demonstrated its dedication to making the best saddle pad in the industry and one that will address the unique needs of the cutting horse.”

5 Star stands for excellence in quality, craftsmanship and materials. Maintaining excellence is a standard which is met by carefully selecting the finest pressed virgin wool felt, leather, mohair and hardware. Products produced always receive full consideration to conformation, movement, natural therapeutic comfort and application. 5 Star produces 100% wool felt pads, mohair cinchas and wool blankets specifically designed to fit what is right for horses.

“I’m a fan of cutting and this sport provides the perfect platform for the type of product we produce,” said 5 Star Equine Products and Supplies owner, Terry Moore. “We are looking forward to being a part of the NCHA corporate partnership team over the next three years and providing the cutting horse rider a product that will be truly beneficial.”

Through the relationship, 5 Star will provide custom embroidered saddle pads to the Top Five in the $50,000 Amateur and $15,000 Amateur at this year’s Mercuria World Finals, as well as custom pads to the winners of both the 2013 Eastern and Western National Championships to be held next year. Furthermore, NCHA’s young riders will see 5 Star pads in the prize package for the Top Ten in the 2014 NYCHA Scholarship Cutting.

The National Cutting Horse Association approves approximately 1,600 events each year with purses totally more than $35 million throughout the sport. Cutting events take place throughout the United States, Canada, Australia, South American and Europe and are supported by such companies as Mercuria Energy, Ram Truck, Great American Insurance Group, the American Quarter Horse Association, John Deere Tractors and XTO Energy among many others.

 

Boehringer Ingelheim Launches Equine Joint Health Management Website

Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the launch of jointhealthmanagement.com, a website dedicated to educating horse owners on the importance of equine joint health management.

Joint health is critical to every horse’s well-being. The impact that stress, injury (acute trauma), everyday use and natural effects of aging can have on a horse’s joints can be quite dramatic. “We know that taking care of horses’ joints is essential to their quality of life,” says Dwana Neal, brand manager, equine pharmaceuticals. “And injuries, regardless of the cause, can lead to degenerative joint disease or osteoarthritis.

Our goal with jointhealthmanagement.com is to provide horse owners a place to find out more about equine joint health, and how to recognize problems and take appropriate action to manage disease.” Joint Health Management is an educational website that provides information on the causes, symptoms, treatment options and the importance of managing the disease. “Our hope is that horse owners will learn more about early detection, prevention, proper treatment, disease management and how it can help maintain the health, longevity and soundness of the horse,” says Neal. “BIVI is dedicated to the health of the horse; the Joint Health Management website helps illustrate our passion and commitment to the industry.”

For more information, please visit jointhealthmanagement.com.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5 percent of its net sales.
For more information, please visit us.boehringer-ingelheim.com and follow us on Twitter at twitter.com/boehringerus.